Bernstein (6) .
It is the purpose of this report to call attention to the very low titer of heterophile antibodies which exists with great constancy in the blood serum of patients with leukemia, to indicate the value of the heterophile antibody test in some conditions differentiated clinically from leukemias with difficulty, and to correlate the findings with previously known data concerning bacterial antibody responses in leukemias. METHODS The technical details and symbols by which the results are recorded are identical with those described by Bernstein (6) in a previous paper which may be consulted.
Heterophile antibodies in conditions other than letukenmia
In normal individuals, and in patients suffering from a variety of diseases, sheep cell agglutinins may be present in dilutions ranging from 1 to 1 up to 1 to 16. Occasionally there will be no agglutination even in the 1 to 1 dilution. In a group of over 300 such cases, 30 per. cent showed no agglutination above 1 to 2 while 70 per cent fell in the range from 1 to 4 up to 1 to 16 (6) . For purposes of convenience, the range below 1 to Under certain circumstances the following diseases may so closely resemble one of the forms of leukemia that clinical differentiation is difficult: acute infections with hyperleukocytosis; miliary tuberculosis; thrombocytopenic purpura; agranulocytic angina; aplastic anemia; erythroleukemia; infectious mononucleosis; Hodgkin's disease; lymphosarcoma; and carcinoma, tuberculosis or syphilis involving lymph glands.
It has already been noted that in infectious mononucleosis heterophile antibodies usually fall in Zone 3. In two or more instances of the rest of the above mentioned maladies except lymphosarcoma, the antibodies are not necessarily confined to Zone 1, but may fall in Zone 2 as well. Unfortunately only one case of lymphosarcoma has been available for study so that no valid conclusions can be drawn concerning it.
Heterophile antibodies in leukemia
In all the forms of leukemia that were studied, with the exception of one case, heterophile antibodies were limited to Zone 1 ( Table I ). The single instance in which the agglutinins were encountered in Zone 2 was found, at autopsy, to represent a chronic myeloid leukemia complicated by an osteomyelitis of the jaw and a healed bacterial endocarditis of the aortic valve (Case 13, Table I ). In the remaining twenty cases which included acute and chronic forms of lymphoid and monocytic, as well as chronic myeloid leukemia, heterophile antibodies were uniformly low. This rule holds true irr.espective of whether or not the patient has received therapy of any sort, including radium or irradiation. For example Case 16 (Table   I ) when first seen, had a leukocyte count of 400,000. Her heterophile agglutinins were 1 to 2. Five weeks later, after intensive x-ray therapy, her that no determinations were carried out at these white blood cell count had fallen to 10,000 but the heterophile agglutinins remained 1 to 2.
Instances in which heterophile antibody determinations proved helpful in clinically confusing conditions
The relevant details of two cases in which doubt existed as to whether or not a leukemia was present, will be presented. In both of these, the conclusions derived in part from heterophile agglutinin determinations were in accord with the diagnosis based on autopsy or biopsy.
Case 22. S. F., a white male, tire builder, aged 36 years, was admitted to the Johns Hopkins Hospital on March 24, 1933 complaining of shortness of breath and weakness. For seven years preceding the onset of the present illness he had worked as an automobile tire builder in which capacity he was constantly exposed to the fumes of benzol.
Early in January, 1933 he developed an acute respiratory infection with a chill, fever, cough and soreness in the chest. From this attack he recovered within a week but from that time on he became weak, suffering from sweats and dyspnoea on exertion.
On admission his temperature was 1030 F. He appeared chronically ill. There was a waxen pallor of the skin and the mucous membranes were almost colorless. In the mouth and over the upper trunk were numerous petechiae. There was slight general glandular enlargement. Neither spleen nor liver could be felt.
The patient's course was steadily downhill. It was characterized by irregular fever, various hemorrhagic phenomena and progressive weakness. He died on May 4, 1933. Examination of the blood at the time of admission showed a depression of all elements with an increase of young myeloid cells. Red blood cells were 3,530,000; hemoglobin was 40 per cent; the leukocytes were 3,800; platelets were 42,000. There was prolongation of the bleeding time, clotting time and the clot retraction. A differential count showed myeloblasts 4 per cent; myelocytes 35 per cent; juvenile neutrophils 19 per cent; segmented neutrophils 5 per cent; basophils 2 per cent; young lymphocytes 25 per cent; adult lymphocytes 10 per cent. Repeated blood cultures were sterile.
The difficulties in diagnosis were obvious. The problem was tersely stated by one observer as follows: "A most confusing case! The story suggests, among other things, benzol poisoning. The blood picture indicates rather an acute myeloid leukemia (aleukemic). The clinical picture might be either of these. It seems to me most likely that this is a case of acute mveloid leukemia (aleukemic) in a man who happens to have been exposed to benzol."
At autopsy there were petechial hemorrhages throughout the organs but no evidence of cellular infiltration. The bone marrow was hyperplastic but full of abnormal young white blood cells. The hyperplasia was considered to have developed because the patient had been removed from benzol for some months before his death, which gave the bone marrow opportunity to attempt to regenerate. The pathological diagnosis was aplastic anemia due to benzol poisoning. The course of her disease was characterized by fever and continued bone pains. Leukocyte counts varied between 8,000 and 22,000 but were usually below 10,000. She was treated with transfusions, liver extract, pentnucleotide and irradiation; all to no avail. An axillary lymph node, removed on November 6, showed an increase of lymphocytes but was not typical of leukemia. Although an aleukemic lymphoid leukemia seemed the most probable diagnosis, splenectomy was carried out on November 14 with the hope that an obscure infection or an atypical Banti's disease might be improved by this measure. The microscopic sections of the spleen showed unmistakable signs of lymphoid leukemia. The patient failed gradually so that in April 1934 she was close to death, with a hemoglobin of 10 per cent.
At the time of splenectomy, sheep cell agglutinins in her blood serum were 1 to 2, a value compatible with leukemia.
The effect of horse serum upon the titer of heterophile antibodies in leukemia In normal individuals the injection of horse serum will elicit, with rare exceptions, an increase in the concentration of sheep cell agglutinins (2). It was deemed proper, therefore, to determine whether or not a patient with leukemia would react similarly. A patient suffering from chronic lymphoid leukemia (Case 9, Table I ), was injected intravenously with two 10 cc. doses of horse serum on successive days. Preliminary skin tests proved him not to be sensitive to the material employed. The heterophile agglutinin titer was measured at frequent intervals (Table II) . The concentration of sheep cell agglutinins did not show any significant variation from the original value over a period of time in which, in a normal individual, the heterophile antibody titer would have increased.
This same experiment was repeated with a second individual (Case 12, Table I ). This was a patient with the hematological findings of lymphoid leukemia who in addition had several large abdominal masses, as well as general glandular enlargement, a picture which was considered to conform iather to leukosarcoma than leukemia. An initial one plus heterophile agglutinin titer of 1 to 1 rose to plus minus at 1 to 4 on the eighteenth day after the injection of horse serum. Such an increase is less both in degree and extent than is encountered in normal individuals treated with horse serum. There was no evidence of serum disease in either of the two patients and it is of passing interest to note that the leukocyte counts, during the period of observation, showed no more than the expected oscillations.
DISCUSSION
Heterophile antibodies in the sera of patients suffering from leukemia are present in low titer. In twenty-one cases of leukemia, a group that embraced lymphoid, myeloid and monocytic types, sheep cell agglutinins were confined to Zone 1 with the exception of one case of chronic myeloid leukemia. In this respect all types of leukemia behave essentially the same. However, in various other diseases which may simulate leukemias, heterophile antibodies were distributed normally in Zones 1 and 2. As an aid in differential diagnosis, this peculiarity of leukemic serum is of definite value. With heterophile agglutinins present in Zone 2 one can conclude with some assurance that the patient whose serum is being tested is not suffering from a leukemia. With the agglutinins confined to Zone 1 the unknown serum may or may not indicate a leukemia. The test gives only negative evidence. By its use a leukemia can probably be ruled out but it will not definitely establish the existence of a leukemia. Case 22 is an example wherein even negative evidence is of importance. The presence of sheep cell agglutinins in Zone 2 suggested that the disease process was not leukemia, a conclusion which was subsequently substantiated by pathological examination. In Case 10 one could only say that the agglutinin titer was compatible with leukemia.
That the mechanism whereby antibodies are formed is disturbed in leukemia has been recognized. In 1914 Moreschi (7) In some of their manifestations leukemias have the characteristics of invasive tumors. It is of interest, then, to note that in patients with cancer there was no depression of heterophile antibodies. Sheep cell agglutinins in several cases of carcinoma originating in the pancreas, as well as in one instance of a hypernephroma with multiple skeletal metastases, were normally distributed in Zones 1 and 2.
SUMMARY
Heterophile agglutinins in the blood sera of twenty-one patients with leukemia were confined to low titers: less than 1 to 4, in twenty instances. In most of the conditions simulating leukemia, heterophile agglutinins were found over a wider distribution of titers up to 1 to 16. Two clinical histories are given as examples of instances in which this differential point was of assistance in arriving at a diagnosis.
Intravenous administration of horse serum which, in a normal person, elicits an increase in the concentration of heterophile antibodies, failed, in one case of lymphoid leukemia, to raise the heterophile antibody titer. In a second case of probable leukosarcoma, horse serum brought about a minimal increase of sheep cell agglutinins. Neither of these patients developed serum disease.
The restriction of heterophile antibody concentrations in leukemia to low titers is in accord with previously known immunological characteristics of individuals with this disease. 
